How Donald Trump was treated successfully: Monoclonal antibodies as alternate defense against COVID-19
Even as vaccines are hailed as our best hope against the coronavirus, dozens of scientific groups are working on an alternate defense: monoclonal antibodies. These therapies shot to prominence just this month after President Trump got an infusion of an antibody cocktail made by Regeneron and credited it for his apparent recovery, even calling it a “cure.”
Scanning electron microscope image of particles that infect a human cell, colored blue, turquoise and yellow. Credit: NIAID (public domain)
Monoclonal antibodies are distilled from the blood of patients who have recovered from the virus. Ideally, antibodies infused early in the course of infection — or even before exposure, as a preventive — may provide swift immunity.